HCA Healthcare, Inc.
NYSE:HCAMedical - Care Facilities
-$12.05 today
- Market cap
- $99.51B
- Beta
- 1.13
- P/E (TTM)
- 12.5
- EPS (TTM)
- $29.98
- Dividend yield
- 0.80%
Volume 1.60M
Average 1.37M
HCA Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
HCA Healthcare, Inc.NYSE: HCA
Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026
Income tax expense grows in line with its trailing trend
Q2 FY2026 income tax expense of $564M rose 7.6% year over year, ahead of the +6.4% change in trailing-twelve-month income tax expense. Sequentially, it rose 31.2% from the prior quarter. Over 3 fiscal years it compounded at +5.5% a year.
Context
- Income tax expense amounted to 2.7% of revenue in FY2025, unchanged from a year earlier.
- Income tax expense increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +7.6% holds above the trailing-twelve-month pace of +6.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Tax Expense history
USD · from the income statement
- Latest · FY2025
- 2.05B USD
- Year-over-year change
- +9.9%
- 4-year CAGR
- -0.7%
| Period | Period end | Income Tax Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.05B | +9.9% |
| FY2024 | 2024-12-31 | 1.87B | +15.5% |
| FY2023 | 2023-12-31 | 1.62B | -7.5% |
| FY2022 | 2022-12-31 | 1.75B | -17.3% |
| FY2021 | 2021-12-31 | 2.11B | — |
Income Tax Expense vs competitors
How HCA compares with its peers on the latest reported figures
- HCA's LTM Jun 2026 income tax expense of $2.02B is the highest of the 6 companies compared; the peer median is $113.55M.
- Its year-over-year change of +6.4% is the 5th highest of 6, against a peer median of +17.7%.
- Income tax expense amounts to 2.6% of revenue for HCA, versus a peer median of 2.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.02B | +6.4% | +5.5% | 2.6% | |
| LTM Jun 2026 | $691M | +17.7% | +8.0% | 3.2% | |
| LTM Jun 2026 | $476.36M | +23.3% | +30.1% | 2.6% | |
| LTM Jun 2026 | $113.55M | +34.5% | +18.0% | 2.0% | |
| LTM Mar 2026 | $108M | +14.9% | -34.4% | 0.5% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $57.09M | -15.9% | +6.8% | 0.9% |
| Peer median (excluding HCA) | $113.55M | +17.7% | +8.0% | 2.0% | |
Competitors are the stored peer set for HCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 58.75B | 60.23B | 64.97B | 70.6B | 75.6B |
| Cost of Revenue | 36.26B | 37.06B | 39.39B | 41.93B | 44.23B |
| Gross Profit | 22.49B | 23.18B | 25.58B | 28.68B | 31.37B |
| Gross Margin | 38.3% | 38.5% | 39.4% | 40.6% | 41.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 26.78B | 27.69B | 29.49B | 31.17B | 8B |
| Operating Expenses | 12.81B | 14.12B | 15.95B | 18.13B | 19.41B |
| Depreciation & Amortization | 2.85B | 2.97B | 3.08B | 3.31B | 3.52B |
| EBITDA | 14.25B | 13.29B | 12.72B | 13.9B | 15.6B |
| EBITDA Margin | 24.3% | 22.1% | 19.6% | 19.7% | 20.6% |
| Operating Income | 9.68B | 9.05B | 9.63B | 10.55B | 11.97B |
| Operating Margin | 16.5% | 15.0% | 14.8% | 14.9% | 15.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.53B | 1.74B | 1.94B | 2.06B | 2.25B |
| Other Income / Expenses | 155M | (473M) | (1.92B) | (2.02B) | (2.13B) |
| Income Before Tax | 9.83B | 8.58B | 7.71B | 8.52B | 9.83B |
| Pre-Tax Margin | 16.7% | 14.2% | 11.9% | 12.1% | 13.0% |
| Income Tax Expense | 2.11B | 1.75B | 1.62B | 1.87B | 2.05B |
| Net Income | 6.96B | 5.64B | 5.24B | 5.76B | 6.78B |
| Net Margin | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
| EPS (Basic) | 21.51 | 19.44 | 19.24 | 22.27 | 28.62 |
| EPS (Diluted) | 21.16 | 19.15 | 18.96 | 22.00 | 28.38 |
| Weighted Avg Shares | 323.32M | 290.35M | 272.4M | 258.6M | 230.71M |
| Weighted Avg Shares (Diluted) | 328.75M | 294.67M | 276.41M | 261.81M | 230.71M |
HCA Healthcare, Inc.
NYSE:HCA
Intrinsic Alpha fair value
Locked
Current Price
$476.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.